Table 2.
Oncological characterization.
| Variable | Total N (%) | Pain N (%) | No pain N (%) | p value |
|---|---|---|---|---|
| Primary tumour location | ||||
| Head and neck | 13 (15.3) | 1 (5.0) | 12 (18.5) | p = 0.070 |
| Digestive | 43 (50.6) | 11 (55.0) | 32 (49.2) | |
| Genitourinary | 5 (5.9) | 0 (0.0) | 5 (7.7) | |
| Breast | 12 (14.1) | 6 (30.0) | 6 (9.2) | |
| Bone | 2 (2.4) | 0 (0.0) | 2 (3.1) | |
| Hidden primary | 1 (1.2) | 1 (5.0) | 0 (0.0) | |
| CNS | 3 (3.5) | 0 (0.0) | 3 (4.6) | |
| Synchronous | 6 (7.1) | 1 (5.0) | 5 (7.7) | |
| Months since diagnosis (months) | ||||
| ⩾60 | 3 (3.5) | 2 (10.0) | 1 (1.5) | p = 0.079 |
| 61–72 | 1 (1.2) | 0 (0.0) | 1 (1.5) | |
| 73–84 | 12 (14.1) | 3 (15.0) | 9 (13.8) | |
| 85–96 | 12 (14.1) | 1 (5.0) | 11 (16.9) | |
| 97–108 | 16 (18.8) | 4 (20.0) | 12 (18.6) | |
| 109–120 | 18 (21.2) | 1 (5.0) | 17 (26.5) | |
| ⩽121 | 23 (27.1) | 9 (45.0) | 14 (21.5) | |
| Metastization | ||||
| No | 74 (87.1) | 17 (85.0) | 57 (87.7) | p = 0.754 |
| Yes | 11 (12.9) | 3 (15.0) | 8 (12.3) | |
χ2 test, p < 0.05. CNS: Central Nervous System.